Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 01.04.14 in Vol 3, No 2 (2014): Apr-Jun

This paper is in the following e-collection/theme issue:

Works citing "Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.3014):

(note that this is only a small subset of citations)

  1. Durães AR, de Souza Roriz P, de Almeida Nunes B, Albuquerque FPE, de Bulhões FV, de Souza Fernandes AM, Aras R. Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study. Drugs in R&D 2016;16(2):149
    CrossRef
  2. Fauchier L, Philippart R, Clementy N, Bourguignon T, Angoulvant D, Ivanes F, Babuty D, Bernard A. How to define valvular atrial fibrillation?. Archives of Cardiovascular Diseases 2015;108(10):530
    CrossRef